Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BLAESE RM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 113 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Okada, T; Shah, M; Higginbotham, JN; Li, Q; Wildner, O; Walbridge, S; Oldfield, E; Blaese, RM; Ramsey, WJ
      AV.TK-mediated killing of subcutaneous tumors in situ results in effectiveimmunization against established secondary intracranial tumor deposits

      GENE THERAPY
    2. Agbaria, R; Candotti, F; Kelley, JA; Hao, Z; Johns, DG; Cooney, DA; Blaese, RM; Ford, H
      Biosynthetic ganciclovir triphosphate: Its isolation and characterization from ganciclovir-treated herpes simplex thymidine kinase-transduced murine cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    3. Candotti, F; Blaese, RM
      Gene therapy for inherited immunodeficiencies

      THERAPEUTIC IMMUNOLOGY, SECOND EDITION
    4. Morris, JC; Ramsey, WJ; Wildner, O; Muslow, HA; Aguilar-Cordova, E; Blaese, RM
      A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma

      HUMAN GENE THERAPY
    5. Christensen, R; Kolvraa, S; Blaese, RM; Jensen, TG
      Development of a skin-based metabolic sink for phenylalanine by overexpression of phenylalanine hydroxylase and GTP cyclohydrolase in primary human keratinocytes

      GENE THERAPY
    6. Candotti, F; Agbaria, R; Mullen, CA; Touraine, R; Balzarini, J; Johns, DG; Blaese, RM
      Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric genefor metabolic suicide gene transfer

      CANCER GENE THERAPY
    7. Walker, RE; Bechtel, CM; Natarajan, V; Baseler, M; Hege, KM; Metcalf, JA; Stevens, R; Hazen, A; Blaese, RM; Chen, CC; Leitman, SF; Palensky, J; Wittes, J; Davey, RT; Falloon, J; Polis, MA; Kovacs, JA; Broad, DF; Levine, BL; Roberts, MR; Masur, H; Lane, HC
      Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection

      BLOOD
    8. Blaese, RM
      Optimism regarding the use of RNA/DNA hybrids to repair genes at high efficiency

      JOURNAL OF GENE MEDICINE
    9. Wildner, O; Blaese, RM; Morris, JC
      Synergy between the herpes simplex virus tk/Ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan

      HUMAN GENE THERAPY
    10. Candotti, F; Facchetti, F; Blanzuoli, L; Stewart, DM; Nelson, DL; Blaese, RM
      Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null'mutations

      GENE THERAPY
    11. Caplen, NJ; Higginbotham, JN; Scheel, JR; Vahanian, N; Yoshida, Y; Hamada, H; Blaese, RM; Ramsey, WJ
      Adeno-retroviral chimeric viruses as in vivo transducing agents

      GENE THERAPY
    12. Wildner, O; Morris, JC; Vahanian, NN; Ford, H; Ramsey, WJ; Blaese, RM
      Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

      GENE THERAPY
    13. Morgan, RA; Blaese, RM
      Gene therapy: lessons learnt from the past decade

      BRITISH MEDICAL JOURNAL
    14. Felzmann, T; Ramsey, WJ; Blaese, RM
      Anti-tumor immunity generated by tumor cells engineered to express B7-1 via retroviral or adenoviral gene transfer

      CANCER LETTERS
    15. Wildner, O; Blaese, RM; Candotti, F
      Enzyme prodrug gene therapy: Synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer

      CANCER RESEARCH
    16. Wildner, O; Blaese, RM; Morris, JC
      Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus thymidine kinase

      CANCER RESEARCH
    17. Onodera, M; Nelson, DM; Sakiyama, Y; Candotti, F; Blaese, RM
      Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: Improved retroviral vectors for clinical trials

      ACTA HAEMATOLOGICA
    18. Candotti, F; Onodera, M; Knazek, RA; Blaese, RM
      Retroviral-mediated transfer and expression of the common gamma chain intohuman hematopoietic progenitors

      ACTA HAEMATOLOGICA
    19. KOHN DB; HERSHFIELD MS; CARBONARO D; SHIGEOKA A; BROOKS J; SMOGORZEWSKA EM; BARSKY LW; CHAN R; BUROTTO F; ANNETT G; NOLTA JA; CROOKS G; KAPOOR N; ELDER M; WARA D; BOWEN T; MADSEN E; SNYDER FF; BASTIAN J; MUUL L; BLAESE RM; WEINBERG K; PARKMAN R
      T-LYMPHOCYTES WITH A NORMAL ADA GENE ACCUMULATE AFTER TRANSPLANTATIONOF TRANSDUCED AUTOLOGOUS UMBILICAL-CORD BLOOD CD34(-DEFICIENT SCID NEONATES() CELLS IN ADA)

      Nature medicine
    20. WALKER RE; CARTER CS; MUUL L; NATARAJAN V; HERPIN BR; LEITMAN SF; KLEIN HG; MULLEN CA; METCALF JA; BASELER M; FALLOON J; DAVEY RT; KOVACS JA; POLIS MA; MASUR H; BLAESE RM; LANE HC
      PERIPHERAL EXPANSION OF PREEXISTING MATURE T-CELLS IS AN IMPORTANT MEANS OF CD4(-CELL REGENERATION HIV-INFECTED ADULTS() T)

      Nature medicine
    21. ZARETSKY JZ; CANDOTTI F; BOERKOEL C; ADAMS EM; YEWDELL JW; BLAESE RM; PLOTZ PH
      RETROVIRAL TRANSFER OF ACID ALPHA-GLUCOSIDASE CDNA TO ENZYME-DEFICIENT MYOBLASTS RESULTS IN PHENOTYPIC SPREAD OF THE GENOTYPIC CORRECTION BY BOTH SECRETION AND FUSION (VOL 8, PG 1555, 1997)

      Human gene therapy
    22. TOURAINE RL; VAHANIAN N; RAMSEY WJ; BLAESE RM
      ENHANCEMENT OF THE HERPES-SIMPLEX VIRUS THYMIDINE KINASE GANCICLOVIR BYSTANDER EFFECT AND ITS ANTITUMOR EFFICACY IN-VIVO BY PHARMACOLOGICALMANIPULATION OF GAP-JUNCTIONS

      Human gene therapy
    23. WILDNER O; CANDOTTI F; KRECKO EG; XANTHOPOULOS KG; RAMSEY WJ; BLAESE RM
      GENERATION OF A CONDITIONALLY NEO(R)-CONTAINING RETROVIRAL PRODUCER CELL-LINE - EFFECTS OF NEO(R) ON RETROVIRAL TITER AND TRANSGENE EXPRESSION

      Gene therapy
    24. Touraine, RL; Ishii-Morita, H; Ramsey, WJ; Blaese, RM
      The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication

      GENE THERAPY
    25. CANDOTTI F; BLAESE RM
      GENE-THERAPY OF PRIMARY IMMUNODEFICIENCIES

      Perspectives in mathematical logic
    26. OKADA T; RAMSEY WJ; MUNIR J; WILDNER O; BLAESE RM
      EFFICIENT DIRECTIONAL CLONING OF RECOMBINANT ADENOVIRUS VECTORS USINGDNA-PROTEIN COMPLEX

      Nucleic acids research
    27. ONODERA M; NELSON DM; YACHIE A; JAGADEESH GJ; BUNNELL BA; MORGAN RA; BLAESE RM
      DEVELOPMENT OF IMPROVED ADENOSINE-DEAMINASE RETROVIRAL VECTORS

      Journal of virology
    28. ONODERA M; ARIGA T; KAWAMURA N; KOBAYASHI I; OHTSU M; YAMADA M; TAME A; FURUTA H; OKANO M; MATSUMOTO S; KOTANI H; MCGARRITY GJ; BLAESE RM; SAKIYAMA Y
      SUCCESSFUL PERIPHERAL T-LYMPHOCYTE-DIRECTED GENE-TRANSFER FOR A PATIENT WITH SEVERE COMBINED IMMUNE-DEFICIENCY CAUSED BY ADENOSINE-DEAMINASE DEFICIENCY

      Blood
    29. RAMSEY WJ; CAPLEN NJ; LI Q; HIGGINBOTHAM JN; SHAH M; BLAESE RM
      ADENOVIRUS VECTORS AS TRANSCOMPLEMENTING TEMPLATES FOR THE PRODUCTIONOF REPLICATION-DEFECTIVE RETROVIRAL VECTORS

      Biochemical and biophysical research communications
    30. RAM Z; CULVER KW; OSHIRO EM; VIOLA JJ; DEVROOM HL; OTTO E; LONG ZF; CHIANG Y; MCGARRITY GEJ; MUUL LM; KATZ D; BLAESE RM; OLDFIELD EH
      THERAPY OF MALIGNANT BRAIN-TUMORS BY INTRATUMORAL IMPLANTATION OF RETROVIRAL VECTOR-PRODUCING CELLS

      Nature medicine
    31. FENJVES ES; SCHWARTZ PM; BLAESE RM; TAICHMAN LB
      KERATINOCYTE GENE-THERAPY FOR ADENOSINE-DEAMINASE DEFICIENCY - A MODEL APPROACH FOR INHERITED METABOLIC DISORDERS

      Human gene therapy
    32. JENSEN TG; SULLIVAN DM; MORGAN RA; TAICHMAN LB; NUSSENBLATT RB; BLAESE RM; CSAKY KG
      RETROVIRUS-MEDIATED GENE-TRANSFER OF ORNITHINE-DELTA-AMINOTRANSFERASEINTO KERATINOCYTES FROM GYRATE ATROPHY PATIENTS

      Human gene therapy
    33. ZARETSKY JZ; CANDOTTI F; BOERKOEL C; ADAMS EM; YEWDELL JW; BLAESE RM; PLOTZ PH
      RETROVIRAL TRANSFER OF ACID ALPHA-GLUCOSIDASE CDNA TO ENZYME-DEFICIENT MYOBLASTS RESULTS IN PHENOTYPIC SPREAD OF THE GENOTYPIC CORRECTION BY BOTH SECRETION AND FUSION

      Human gene therapy
    34. ONODERA M; YACHIE A; NELSON DM; WELCHLIN H; MORGAN RA; BLAESE RM
      A SIMPLE AND RELIABLE METHOD FOR SCREENING RETROVIRAL PRODUCER CLONESWITHOUT SELECTABLE MARKERS

      Human gene therapy
    35. ISHIIMORITA H; AGBARIA R; MULLEN CA; HIRANO H; KOEPLIN DA; RAM Z; OLDFIELD EH; JOHNS DG; BLAESE RM
      MECHANISM OF BYSTANDER EFFECT KILLING IN THE HERPES-SIMPLEX THYMIDINEKINASE GENE-THERAPY MODEL OF CANCER-TREATMENT

      Gene therapy
    36. FELZMANN T; RAMSEY WJ; BLAESE RM
      CHARACTERIZATION OF THE ANTITUMOR IMMUNE-RESPONSE GENERATED BY TREATMENT OF MURINE TUMORS WITH RECOMBINANT ADENOVIRUSES EXPRESSING HSVTK, IL-2, IL-6 OR B7-1

      Gene therapy
    37. WATANABE C; ZHU Q; LIU T; HOLLENBAUGH D; BLAESE RM; KANNER SB; ARUFFO A; OCHS HD
      THE WISKOTT-ALDRICH SYNDROME - WASP-MUTATIONS AND THEIR EFFECT ON GENE-TRANSCRIPTION AND PROTEIN EXPRESSION CORRELATE WITH CLINICAL PHENOTYPES

      Journal of allergy and clinical immunology
    38. CHEN M; CANDOTTI F; OAKES SA; VEZZONI P; BLAESE RM; NOTARANGELO LD; VILLA A; OSHEA JJ
      JAK3 SCID - MUTATIONS IN NONCATALYTIC DOMAIN AND BASIS OF JAK3-GAMMA-C INTERACTION

      Journal of allergy and clinical immunology
    39. BLAESE RM
      GENE-THERAPY FOR CANCER

      Scientific American
    40. TAICHMAN LB; SHILLITOE EJ; OCONNELL BC; CHENG SH; BLAESE RM
      HUMAN GENE-THERAPY PROGRESS AND PROSPECTS

      Journal of dental research
    41. ZHU QL; WATANABE C; LIU T; HOLLENBAUGH D; BLAESE RM; KANNER SB; ARUFFO A; OCHS HD
      WISKOTT-ALDRICH-SYNDROME X-LINKED THROMBOCYTOPENIA - WASP GENE-MUTATIONS, PROTEIN EXPRESSION, AND PHENOTYPE/

      Blood
    42. KOHN DB; WEINBERG KI; SHIGEOKA A; CARBONARO D; BROOKS J; SMOGORZEWSKA EM; BARSKY LW; ANNETT G; NOLTA JA; KAPOOR N; CROOKS GM; ELDER M; WARA D; BOWEN T; MUUL L; HERSHFIELD M; BLAESE RM; PARKMAN R
      PEG-ADA REDUCTION IN RECIPIENTS OF ADA GENE-TRANSDUCED AUTOLOGOUS UMBILICAL-CORD BLOOD CD34+ CELLS

      Blood
    43. MORGAN RA; BUNNELL B; WALKER R; LANE C; BLAESE RM
      AN AIDS GENE-THERAPY TRIAL IN HIV-1 DISCORDANT IDENTICAL-TWINS

      Blood
    44. CANDOTTI F; OAKES SA; JOHNSTON JA; GILIANI S; SCHUMACHER RF; MELLA P; FIORINI M; UGAZIO AG; BADOLATO R; NOTARANGELO LD; BOZZI F; MACCHI P; STRINA D; VEZZONI P; BLAESE RM; OSHEA JJ; VILLA A
      STRUCTURAL AND FUNCTIONAL BASIS FOR JAK3-DEFICIENT SEVERE COMBINED IMMUNODEFICIENCY

      Blood
    45. LIU T; ZHU Q; BLAESE RM; JUNKER AK; OCHS HD
      ALTERNATIVE SPLICING OF THE WISKOTT-ALDRICH SYNDROME (WAS) GENE MAY AFFECT PHENOTYPE

      Journal of investigative medicine
    46. WU L; ZHU Q; HOLLENBAUGH D; BLAESE RM; JUNKER AK; ARUFFO A; OCHS HD
      THE WISKOTT-ALDRICH SYNDROME PROTEIN

      Journal of investigative medicine
    47. OAKES SA; CANDOTTI F; JOHNSTON JA; CHEN YQ; RYAN JJ; TAYLOR N; LIU XW; HENNIGHAUSEN L; NOTARANGELO LD; PAUL WE; BLAESE RM; OSHEA JJ
      SIGNALING VIA IL-2 AND IL-4 IN JAK3-DEFICIENT SEVERE COMBINED IMMUNODEFICIENCY LYMPHOCYTES - JAK3-DEPENDENT AND INDEPENDENT PATHWAYS

      Immunity
    48. MULLEN CA; SNITZER K; CULVER KW; MORGAN RA; ANDERSON WF; BLAESE RM
      MOLECULAR ANALYSIS OF T-LYMPHOCYTE-DIRECTED GENE-THERAPY FOR ADENOSINE-DEAMINASE DEFICIENCY - LONG-TERM EXPRESSION IN-VIVO OF GENES INTRODUCED WITH A RETROVIRAL VECTOR

      Human gene therapy
    49. WALKER RE; BLAESE RM; DAVEY RT; FALLOON J; MULLEN C; POLIS MA; FINER M; MCGUIRE B; ROBERTS M; ZSEBO K; HAVRILLA N
      A PHASE-I II PILOT-STUDY OF THE SAFETY OF THE ADOPTIVE TRANSFER OF SYNGENEIC GENE-MODIFIED CYTOTOXIC T-LYMPHOCYTES IN HIV-INFECTED IDENTICAL-TWINS - CELL-GENESYS-INC PROTOCOL T-9401-BB-IND-5610/

      Human gene therapy
    50. MORGAN RA; WALKER R; BLAESE RM; CARTER CS; DAVEY RT; FALLOON J; KLEIN H; LANE HC; LEITMAN SF; POLIS MA
      GENE-THERAPY FOR AIDS USING RETROVIRAL-MEDIATED GENE-TRANSFER TO DELIVER HIV-1 ANTISENSE TAR AND TRANSDOMINANT REV PROTEIN GENES TO SYNGENEIC LYMPHOCYTES IN HIV-1-INFECTED IDENTICAL-TWINS

      Human gene therapy
    51. ZHU O; HOLLENBAUGH D; LIU T; WU L; KANNER S; GARRIGUES J; BLAESE RM; GOWN A; ARUFFO A; OCHS HD
      THE WISKOTT-ALDRICH SYNDROME PROTEIN

      The FASEB journal
    52. CANDOTTI F; BLAESE RM
      THE USE OF GENE-THERAPY FOR IMMUNODEFICIENCY DISEASE

      Immunology and allergy clinics of North America
    53. BLAESE RM; CULVER K; KOHN D; MORGAN R; MILLER AD; ANDERSON WF; TOURAINE R; RAMSEY WJ; RAM Z; OLDFIELD E
      GENE-THERAPY

      Vox sanguinis
    54. LIU T; ZHU OL; BLAESE RM; JUNKER SK; WINKELSTEIN J; OCHS HD
      SPLICE-SITE MUTATIONS IN THE WISKOTT-ALDRICH SYNDROME

      Pediatric research
    55. FENJVES ES; SCHWARTZ PM; BLAESE RM; TAICHMAN LB
      EPIDERMAL GENE-THERAPY FOR INHERITED METABOLIC DISORDERS

      Journal of investigative dermatology
    56. CANDOTTI F; OAKES SA; JOHNSTON JA; NOTARANGELO LD; OSHEA JJ; BLAESE RM
      IN-VITRO CORRECTION OF JAK3-DEFICIENT SEVERE COMBINED IMMUNODEFICIENCY BY RETROVIRAL-MEDIATED GENE TRANSDUCTION

      The Journal of experimental medicine
    57. SEKHSARIA S; FLEISHER TA; VOWELLS S; BROWN M; MILLER J; GORDON I; BLAESE RM; DUNBAR CE; LEITMAN S; MALECH HL
      GRANULOCYTE-COLONY-STIMULATING FACTOR RECRUITMENT OF CD34(-BLOOD - IMPAIRED MOBILIZATION IN CHRONIC GRANULOMATOUS-DISEASE AND ADENOSINE DEAMINASE-DEFICIENT SEVERE COMBINED IMMUNODEFICIENCY DISEASE PATIENTS() PROGENITORS TO PERIPHERAL)

      Blood
    58. BLAESE RM
      STEPS TOWARD GENE-THERAPY .2. CANCER AND AIDS

      Hospital practice
    59. BLAESE RM
      STEPS TOWARD GENE-THERAPY .1. THE INITIAL TRIALS

      Hospital practice
    60. KOHN DB; WEINBERG KI; NOLTA JA; HEISS LN; LENARSKY C; CROOKS GM; HANLEY ME; ANNETT G; BROOKS JS; ELKHOUREIY A; LAWRENCE K; WELLS S; MOEN RC; BASTIAN J; WILLIAMSHERMAN DE; ELDER M; WARA D; BOWEN T; HERSHFIELD MS; MULLEN CA; BLAESE RM; PARKMAN R
      ENGRAFTMENT OF GENE-MODIFIED UMBILICAL-CORD BLOOD-CELLS IN NEONATES WITH ADENOSINE-DEAMINASE DEFICIENCY

      Nature medicine
    61. BORDIGNON C; BONINI C; VERZELETTI S; NOBILI N; MAGGIONI D; TRAVERSARI C; GIAVAZZI R; SERVIDA P; ZAPPONE E; BENAZZI E; BERNARDI M; PORTA F; FERRARI G; MAVILIO F; ROSSINI S; BLAESE RM; CANDOTTI F
      TRANSFER OF THE HSV-TK GENE INTO DONOR PERIPHERAL-BLOOD LYMPHOCYTES FOR IN-VIVO MODULATION OF DONOR ANTITUMOR IMMUNITY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Human gene therapy
    62. OLDFIELD EH; RAM Z; CHIANG YW; BLAESE RM
      INTRATHECAL GENE-THERAPY FOR THE TREATMENT OF LEPTOMENINGEAL CARCINOMATOSIS

      Human gene therapy
    63. KWAN SP; HAGEMANN TL; BLAESE RM; KNUTSEN A; ROSEN FS
      SCANNING OF THE WISKOTT-ALDRICH SYNDROME (WAS) GENE - IDENTIFICATION OF 18 NOVEL ALTERATIONS INCLUDING A POSSIBLE MUTATION HOTSPOT AT ARG86RESULTING IN THROMBOCYTOPENIA, A MILD WAS PHENOTYPE

      Human molecular genetics
    64. OSHIRO EM; VIOLA JJ; OLDFIELD EH; WALBRIDGE S; BACHER J; FRANK JA; BLAESE RM; RAM Z
      TOXICITY STUDIES AND DISTRIBUTION DYNAMICS OF RETROVIRAL VECTORS FOLLOWING INTRATHECAL ADMINISTRATION OF RETROVIRAL VECTOR-PRODUCER CELLS

      Cancer gene therapy
    65. BUNNELL BA; MUUL LM; BLAESE RM; MORGAN RA
      HIGH-EFFICIENCY RETROVIRAL-MEDIATED GENE-TRANSFER INTO HUMAN PERIPHERAL-BLOOD LYMPHOCYTES FOR HIV-1 GENE-THERAPY

      AIDS research and human retroviruses
    66. MORGAN RA; CHUAH M; VANDENDRIESSCHE T; BUNNELL B; BRESSLER P; WALKER R; LANE C; BLAESE RM
      COMPARISON OF ANTI-HIV-1 RETROVIRAL VECTORS AND THEIR USE IN AN AIDS GENE-THERAPY TRIAL IN IDENTICAL-TWINS

      AIDS research and human retroviruses
    67. WALKER RE; CARTER CS; MUUL L; NATARAJAN V; HERPIN BR; LEITMAN SF; KLEIN HG; FALLOON J; DAVEY RT; KOVACS JA; POLIS MA; MASUR H; BLAESE RM; LANE HC
      SURVIVAL AND DISTRIBUTION OF GENETICALLY-MODIFIED CELLS IN IDENTICAL-TWINS DISCORDANT FOR HIV-1 INFECTION

      AIDS research and human retroviruses
    68. KWAN SP; HAGEMANN TL; BLAESE RM; ROSEN FS
      A HIGH-RESOLUTION MAP OF GENES, MICROSATELLITE MARKERS, AND NEW DINUCLEOTIDE REPEATS FROM UBE1 TO THE GATA LOCUS IN THE REGION XP11.23

      Genomics
    69. RAMSEY WJ; MULLEN CA; BLAESE RM
      RETROVIRUS-MEDIATED GENE-TRANSFER AS THERAPY FOR ADENOSINE-DEAMINASE (ADA) DEFICIENCY

      Leukemia
    70. FENIVES ES; BLAESE RM; TAICHMAN LB
      CUTANEOUS GENE-THERAPY FOR ADA DEFICIENCY - A MODEL APPROACH FOR INHERITED METABOLIC DISORDERS

      Journal of cellular biochemistry
    71. MORGAN RA; CHUAH M; VANDENDRIESSCHE T; BUNNELL B; BRESSLER P; WALKER R; LANE C; BLAESE RM
      COMPARISON OF ANTI-HIV-1 RETROVIRAL VECTORS AND THEIR USE IN AN AIDS GENE-THERAPY TRIAL IN IDENTICAL-TWINS

      Journal of cellular biochemistry
    72. FELZMANN T; RAMSEY J; BLAESE RM
      DEVELOPMENT OF ANIMAL-MODELS FOR THE TREATMENT OF HUMAN PAPILLOMA-VIRUS INDUCED CARCINOMAS

      Journal of cellular biochemistry
    73. WANNEBO C; MUUL L; CARTER C; CHANG L; MAY F; READ EJ; BLAESE RM; KLEIN HG
      MAGNETIC BEAD DEPLETION OF CD8(-LYMPHOCYTES FROM PERIPHERAL MONONUCLEAR-CELLS FOR USE IN HUMAN GENE-THERAPY() T)

      Transfusion
    74. BLAESE RM; CULVER KW; MILLER AD; CARTER CS; FLEISHER T; CLERICI M; SHEARER G; CHANG L; CHIANG YW; TOLSTOSHEV P; GREENBLATT JJ; ROSENBERG SA; KLEIN H; BERGER M; MULLEN CA; RAMSEY WJ; MUUL L; MORGAN RA; ANDERSON WF
      T-LYMPHOCYTE-DIRECTED GENE-THERAPY FOR ADA(-) SCID - INITIAL TRIAL RESULTS AFTER 4 YEARS

      Science
    75. KOHN DB; WEINBERG KI; LENARSKY C; CROOKS G; HEISS LN; NOLTA JA; WARA D; ELDER M; WILLIAMSHERMAN D; BOWEN T; MOEN RC; BLAESE RM
      GENE-THERAPY FOR NEONATES WITH ADA DEFICIENCY BY TRANSFER OF THE HUMAN ADA CDNA INTO UMBILICAL-CORD CD34-YEAR FOLLOW-UP( CELLS 2)

      Pediatric research
    76. BUNNELL BA; MUUL LM; DONAHUE RE; BLAESE RM; MORGAN RA
      HIGH-EFFICIENCY RETROVIRAL-MEDIATED GENE-TRANSFER INTO HUMAN AND NONHUMAN PRIMATE PERIPHERAL-BLOOD LYMPHOCYTES

      Proceedings of the National Academy of Sciences of the United Statesof America
    77. KWAN SP; HAGEMANN TL; RADTKE BE; BLAESE RM; ROSEN FS
      IDENTIFICATION OF MUTATIONS IN THE WISKOTT-ALDRICH SYNDROME GENE AND CHARACTERIZATION OF A POLYMORPHIC DINUCLEOTIDE REPEAT AT DXS6940, ADJACENT TO THE DISEASE GENE

      Proceedings of the National Academy of Sciences of the United Statesof America
    78. RAM Z; CULVER K; OSHIRO E; VIOLA J; DEVROOM H; OTTO E; LONG Z; MCGARRITY G; MUUL L; KATZ D; BLAESE RM
      SUMMARY OF RESULTS AND CONCLUSIONS OF THE GENE-THERAPY OF MALIGNANT BRAIN-TUMORS - CLINICAL-STUDY

      Journal of neurosurgery
    79. KOHN DB; WEINBERG KI; LENARSKY C; CROOKS GM; HEISS LN; NOLTA JA; SMOGORZEWSKA EM; BASTIAN J; WARA D; ELDER M; BOWEN T; HERSHFIELD M; BLAESE RM; PARKMAN R
      SELECTIVE ACCUMULATION OF ADA GENE-TRANSDUCED T-LYMPHOCYTES UPON PEG-ADA DOSAGE REDUCTION AFTER GENE-THERAPY WITH TRANSDUCED CD34-CORD BLOOD-CELLS( UMBILICAL)

      Blood
    80. SEKHSARIA S; FLEISHER TA; VOWELLS SJ; BROWN M; MILLER JA; GORDON I; BLAESE RM; LEITMAN SF; MALECH HL
      KINETICS OF G-CSF RECRUITMENT OF PERIPHERAL-BLOOD CD34- NORMAL VOLUNTEERS AND 2 PATIENT GROUPS WITH INHERITED( CELLS )

      Blood
    81. ZHU QL; ZHANG M; BLAESE RM; DERRY JMJ; JUNKER A; FRANCKE U; CHEN SH; OCHS HD
      THE WISKOTT-ALDRICH SYNDROME AND X-LINKED CONGENITAL THROMBOCYTOPENIAARE CAUSED BY MUTATIONS OF THE SAME GENE

      Blood
    82. ZARETSKY JZ; CANDOTTI F; BOERKOEL N; RABEN N; NICHOLS RC; BLAESE RM; PLOTZ PH
      ACID ALPHA-MALTASE DEFICIENCY - APPROACH TO GENE-THERAPY

      American journal of human genetics
    83. CULVER KW; VANGILDER J; LINK CJ; CARLSTROM T; BUROKER T; YUH W; KOCH K; SCHABOLD K; DOORNBAS S; WETJEN B; BLAESE RM
      GENE-THERAPY FOR THE TREATMENT OF MALIGNANT BRAIN-TUMORS WITH IN-VIVOTUMOR TRANSDUCTION WITH THE HERPES-SIMPLEX THYMIDINE KINASE GENE GANCICLOVIR SYSTEM

      Human gene therapy
    84. KOTANI H; NEWTON PB; ZHANG SY; CHIANG YWL; OTTO E; WEAVER L; BLAESE RM; ANDERSON WF; MCGARRITY GJ
      IMPROVED METHODS OF RETROVIRAL VECTOR TRANSDUCTION AND PRODUCTION FORGENE-THERAPY

      Human gene therapy
    85. BLAESE RM; ISHIIMORITA H; MULLEN C; RAMSEY J; RAM Z; OLDFIELD E; CULVER K
      IN-SITU DELIVERY OF SUICIDE GENES FOR CANCER-TREATMENT

      European journal of cancer
    86. CANDOTTI F; MULLEN CA; BLAESE RM
      USE OF A COMBINED POSITIVE NEGATIVE SELECTABLE GENE FOR RETROVIRAL-MEDIATED GENE-TRANSFER/

      Journal of cellular biochemistry
    87. ISHII H; AGBARIA R; HIRANO H; RAM Z; OLDFIELD E; JOHNS DG; BLAESE RM
      MECHANISM OF BYSTANDER EFFECT KILLING IN THE HERPES-SIMPLEX THYMIDINEKINASE GENE-MODIFIED TUMOR SYSTEM

      Journal of cellular biochemistry
    88. KOHN DB; WEINBERG KI; PARKMAN R; LENARSKY C; CROOKS GM; SHAW K; HANLEY ME; LAWRENCE K; ANNETT G; BROOKS JS; WARA D; ELDER M; BOWEN T; HERSHFIELD MS; BERENSON RI; MOEN RC; MULLEN CA; BLAESE RM
      GENE-THERAPY FOR NEONATES WITH ADA-DEFICIENT SCID BY RETROVIRAL-MEDIATED TRANSFER OF THE HUMAN ADA CDNA INTO UMBILICAL-CORD CD34+ CELLS

      Journal of cellular biochemistry
    89. MULLEN CA; SNITZER K; BLAESE RM
      LONG-TERM IN-VIVO EXPRESSION OF RETROVIRALLY TRANSFERRED ADA GENES INLYMPHOCYTE CLONES FROM AN ADA-SCID PATIENT TREATED WITH GENE-THERAPY

      Journal of cellular biochemistry
    90. CULVER KW; BLAESE RM
      GENE-THERAPY FOR CANCER

      Trends in genetics
    91. KOHN DB; WEINBERG KI; LENARSKY C; CROOKS GM; HANLEY ME; LAWRENCE K; ANNETT G; BROOKS JS; WARA D; ELDER M; WILLIAMSHERMAN D; BOWEN T; HERSHFIELD MS; BERENSON RI; MOEN RC; MULLEN CA; BLAESE RM; PARKMAN R
      GENE-THERAPY FOR NEONATES WITH ADENOSINE-DEAMINASE (ADA) DEFICIENT SCID BY RETROVIRAL-MEDIATED TRANSFER OF THE HUMAN ADA CDNA INTO UMBILICAL-CORD CD34+ CELLS

      Pediatric research
    92. AGBARIA R; MULLEN CA; HARTMAN NR; COONEY DA; HAO Z; BLAESE RM; JOHNS DG
      EFFECTS OF IMP DEHYDROGENASE INHIBITORS ON THE PHOSPHORYLATION OF GANCICLOVIR IN MOLT-4 CELLS BEFORE AND AFTER HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE TRANSDUCTION

      Molecular pharmacology
    93. SULLIVAN KE; MULLEN CA; BLAESE RM; WINKELSTEIN JA
      A MULTIINSTITUTIONAL SURVEY OF THE WISKOTT-ALDRICH SYNDROME

      The Journal of pediatrics
    94. RAM Z; WALBRIDGE S; SHAWKER T; CULVER KW; BLAESE RM; OLDFIELD EH
      THE EFFECT OF THYMIDINE KINASE TRANSDUCTION AND GANCICLOVIR THERAPY ON TUMOR VASCULATURE AND GROWTH OF 9L GLIOMAS IN RATS

      Journal of neurosurgery
    95. RAM Z; WALBRIDGE S; HEISS JD; CULVER KW; BLAESE RM; OLDFIELD EH
      IN-VIVO TRANSFER OF THE HUMAN INTERLEUKIN-2 GENE - NEGATIVE TUMORICIDAL RESULTS IN EXPERIMENTAL BRAIN-TUMORS

      Journal of neurosurgery
    96. MISHRA BB; FERNANDES AM; BLAESE RM; MUCHMORE AV
      CHARACTERIZATION OF T-CELL LIGANDS FOR UROMODULIN - A POSSIBLE ROLE IN COSTIMULATION

      Cellular immunology
    97. RAM Z; WALBRIDGE S; OSHIRO EM; VIOLA JJ; CHIANG YW; MUELLER SN; BLAESE RM; OLDFIELD EH
      INTRATHECAL GENE-THERAPY FOR MALIGNANT LEPTOMENINGEAL NEOPLASIA

      Cancer research
    98. MULLEN CA; COALE MM; LOWE R; BLAESE RM
      TUMORS EXPRESSING THE CYTOSINE DEAMINASE SUICIDE GENE CAN BE ELIMINATED IN-VIVO WITH 5-FLUOROCYTOSINE AND INDUCE PROTECTIVE IMMUNITY TO WILD-TYPE TUMOR

      Cancer research
    99. FLEISHER TA; BLAESE RM
      NEW APPROACHES IN THE THERAPY OF IMMUNODEFICIENCY

      Allergy proceedings
    100. CORNETTA K; NGUYEN N; MORGAN RA; MUENCHAU DD; HARTLEY JW; BLAESE RM; ANDERSON WF
      INFECTION OF HUMAN-CELLS WITH MURINE AMPHOTROPIC REPLICATION-COMPETENT RETROVIRUSES

      Human gene therapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 06:04:03